Modern methods for the prevention of implant-associated infections;Moderne methoden zur prävention von implantatassoziierten nosokomialen infektionen

Hygiene + Medizin

Volumn 26, Issue 7-8, 2001, Pages 280-287

  Kohnen, W ^a   Jansen, B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Bloodstream infection; Catheter associated infection; Implants; Nosocomial infections

Indexed keywords

ANTIBIOTIC AGENT; BENZALKONIUM CHLORIDE; BIOMATERIAL; CHLORHEXIDINE; MINOCYCLINE; POLYMER; RIFAMPICIN; SULFADIAZINE SILVER;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIUM ADHERENCE; CENTRAL VENOUS CATHETER; CEREBROSPINAL FLUID FISTULA; COAGULASE NEGATIVE STAPHYLOCOCCUS; FOREIGN BODY; GRAFT INFECTION; HEART ASSIST DEVICE; HEART VALVE PROSTHESIS; HOST RESISTANCE; HUMAN; IMPLANT; INFECTION RATE; ORTHOPEDIC EQUIPMENT; REVIEW; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0034884147     PISSN: 01723790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Infections that complicate the insertion of prosthetic devices
2. Left ventricular assist device infection is associated with increased mortality but is not a contradiction to transplantation
3. Infections associated with prosthetic devices. Magnitude of the problem
4. Intravenous-related infections
5. Mechanisms and clinical relevance of bacterial adhesion to polymers
6. New aspects in the pathogenesis and prevention of polymer-associated foreign body infections caused by coagulase-negative staphylococci
7. New aspects in the molecular basis of polymer-associated infections due to Staphylococci
8. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: Purification and structural analysis
9. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface
10. Occurrence of capsular polysaccharide adhesin among clinical isolates of coagulase-negative staphylococci
11. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response
12. Adhesive colonization of biomaterials and antibiotic resistance
13. Vascular catheter-related infection: Aetiology and prevention
14. Difficult-to-treat infections: Foreign body infections
15. Guidelines for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee
16. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheter in hospitalized patients
17. Intravascular catheter-related sepsis-novel methods of prevention
18. Correlation between free energy for adhesion and bacterial adhesion to polymers-the minimum adherence hypothesis
19. Prevention of biofilm formation by polymer modification
20. Identification of D motif epitopes in Staphylococcus aureus fibronectin binding
21. Modem strategies in the prevention of polymer-associated infections
22. Current approaches to the prevention of catheter-related infections
23. Antibiotics in acrylic bone cement
24. "Intelligent" polymers in medicine and biotechnology
25. Intelligent polymers for the prevention of device-related infection
26. Prevention of Intravascular Catheter-Related Infections
27. Are nosocomial infection rates in intensive care units useful benchmark parameters?
28. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion
29. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping
30. Femoral deep vein thrombosis associated with central venous catheterization: Results from a prospective, randomized trial
31. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition?
32. Perioperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: A randomized, controlled study
33. The role of understaffing in central venous catheter-associated bloodstream infections
34. Prevention of peripheral venous catheter complications with an intravenous therapy team: A randomized controlled study
35. Transparent polyurethane film as an intravenous catheter dressing. A metaanalysis of the infection risks
36. Meta-analysis of transparent vs. gauze dressings for central venous catheter use
37. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection
38. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine
39. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: Effect of mupirocin ointment
40. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters
41. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment
42. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients
43. Staphylococcus aureus nasal colonization in patients with cirrhosis: Prospective assessment of association with infection
44. Nasal carriage and infection with Staphylococcus aureus in HIV-infected patients
45. Microparticulate-induced phlebitis. Its prevention by in-line filtration
46. In-vitro efficacy of a central venous catheter ("Hydrocath") loaded with teicoplanin to prevent bacterial colonization
47. In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization
48. In-vitro activity of a catheter loaded with silver and teicoplanin to prevent bacterial and fungal colonization
49. In vitro and in vivo efficacy of a rifampicinloaded silicone catheter for the prevention of CSF shunt infections
50. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters
51. Central venous catheters coated with minocycline, and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, doubleblind trial
52. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter - A randomized, controlled trial
53. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection
54. A comparison of two antimicrobial-impregnated central venous catheters
55. Intravascular catheters impregnated with benzalkonium chloride
56. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: Results from a prospective, randomized trial
57. In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter
58. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients
59. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter
60. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infections
61. Anti-microbial or antiseptic impregnated central venous catheters: Update on a "central" debate
62. Possible link between bacterial resistance and use of antibiotics and biocides
63. Anaphylactic shock induced by an antiseptic-coated central venous catheter